Investors

REGISTERED INVESTORS - NOVEMBER 2019
as of 10/24/2019

Aisling Capital
AKS Family Partners

Alta Capital

Alta Semper Capital LLP (Lauder FO)

Apollo Ventures

​Anavex Life Sciences Corp.

Artiman Ventures

BDC Healthcare Fund

BioInnovation Capital

BioMotiv

BioSense Global

Blue Ox Healthcare Partners, LLC

Boehringer Ingelheim Venture Fund

Boston Millennia Partners

China Grand Enterprise

Colle Capital

Cowin Venture

Dabar Investment Associates

De Novo Ventures

Delos Capital

DesVoeux Guilford Capital (FO)

Double U Fund

East West Capital Partners

Easton Capital

EBO Global Innovation Capital

Elmcore

EnBiotix

Epicheirisi Ventures

Eric Hargarten

Esousa Holdings LLC

Fane Family Office

Focused Ultrasound

Fortress Biotech

Gonzalez Family Office

Good Health Capital New York

Gore Range Capital

Health Catalyst Capital Management LLC

HI Investors

HighCape Capital

I2BF Venture Capital

Illumina Ventures

Industrifonden

Joseph Ventures

Kingdon Foundation

Laurence Rulleau 

Leukemia and Lymphoma Society

Lionchase Holdings

Litte Gem Life Science

MaidStone Life Sciences

Mass Medical Angels

MedPro Investors

Merck

MK Technology

National Foundation for Cancer Research

Nieuw Amsterdam

Novatio Ventures

Omnibus Capital LLC

Park Avenue Capital

Paul Ritcher

PHS Capital

Pfizer, Inc.

Philips

Premier Partners, LLC

Prevail Partners

PYCAP VENTURE PARTNERS

Red Hook Asset Management

Sound Affects

Stare Health Network

SVVG Partners LLLP

Taiho Ventures

Time BioVentures

TT Capital Partners

VCapital

Vista Capital

Vyera Pharmaceuticals, LLC

WP Global Partners

 

REGISTERED INVESTORS - MARCH 2019

3e Bioventures

AIM-HI Fund

Apeiron Holdings

Ascentia Asset Management

Asia America Group

ATEM Capital

Bayer
Boehringer Ingelheim Venture Fund

Boston Millennia Partners

Bridle Path

Chaperone Investment

Dana Farber Cancer Center Investors

Dandrew Encore Venture Capital

Delos Capital

Des Voeux Guilford Capital

EXXclaim Capital

FasterCapital

FC Capital

Fotress Biotech

Fortunatus Capital

GIS Strategic Venture Capital (Guardian Life)

GrayBella

GSK / SROne Fund

Harvard Innovation Labs

HBM Capital

Healthcare Royalty Partners

HI Investors

Innogest

Integrium 

Ironwood Funds

Johnson and Johnson Innovation

Julien Family Office

Leukemia and Lymphoma Society TAP Venture Program 

Longwood Fund

Lumira Capital

Marwood Group

Mass Medical Angels

Merck

M-Ventures (Merck Germany)

Meridian Medical

Mitsui Global Investment (MGI)
MPM Capital

My Bio Gate

Nieuw Amsterdam Advisors (MFO)
Novatio Ventures

Park Avenue Capital Management

PBM Capital

Pharma Connections Worldwide

Philips Corporate Venture Division

POSCO Capital

Previal Partners
Privo Technologies

Puck Ventures

Samsung Ventures

Schooner Capital

Springhood Ventures

Temasek Holdings

Technology Incubation Program @UCONN

V2M Capital

Vertex Ventures

VI Ventures

WuXi

REGISTERED INVESTORS - OCTOBER 2018 CONFERENCE

1812 Ventures

3e Bioventures

AIM-HI / National Foundation for Cancer Research

AKS Family Partners

Alpha Square Group

Aisling Capital

AltaCap

Anup Singh (individual investor)

Aranmore Advisors

ARD Healthcare

Band of Angels

BioSense Global

Blue Ox (Family Office)

Boler Biotech 

Business Development Bank of Canada

Canadian Innovation Lab

Cancer Prevention and Research Institute of Texa

Cancer Research Institute

Canepa Healthcare

Chaperone Investment

Clemente Advisors, LLC

Cross Road Biotech Inversiones Biotecnológicas

Dabar Investment Associates

Dandrew Partners

Dartmouth Ventures

Easton Capital

Edelson Technology Partners

Ellington Healthcare Partners

Enso Ventures

Esousa

Excelyrate Capital

First Round Capital

Fortress Biotech

Fortunatus Capital

Gonzalez Family Office

Gore Range Capital

GCF Family Office

GSK - SR One Fund

Guardian Life - GIS Strategic Ventures

Harald Duell - Private Investor

Health Catalyst Capital LP

Healthbox (Intermountain Health VC Fund)

HI Investors

HJ Capital

iLab Ventures (LEO Pharma’s Digital Health VC)

iNetworks Opportunity Fund

Innogest Capital

International Cancer Impact Fund

Intrinsic Value Capital

Jina Ventures

JZ Capital / Jordan Family Office

Kingdon Foundation

Landmark Family Office

LEAF Single Family Office

Leukemia and Lymphoma Society - Therapy Acceleration Program (LLS)

LifeTech Capital

LLEX Partners

LSWorks

Lymo Ventures

MaidStone Life Sciences

Mass Medical Angels

MedPro Investors

Merck - Global Health Innovation Fund (GHI)

Monarch Holdings

Murdock Capital

Northern Light Venture Capital

NSIP LLC

Oakdene Capital

Park Avenue Capital

PBM Capital

Pfizer

Prevail Partners

Purdue Pharma / Greenfield Bioventures / Sackler FO

Remiges Ventures

Samsung Corporation

Sandbox (Blue Cross/Blue Shield's Venture Capital Fund)

Santé Ventures

Skylight Investment

Silicon Valley Ventures Growth Partners LLP

Sound Affects

Touchdown Ventures

Two Sigma Ventures

Verena Capital

Vista Capital Advisors

Volcano Capital

Yafo Capital

Vector Capital

REGISTERED INVESTORS - MAY 2018 CONFERENCE

ADDF 

AIM-HI Cancer Fund
Aleph Capital 
Aisling Capital

Arix Biosciences

ATEM Capital 

Beechwood FO

Biosense Global

Boston Millenia Partners

Broms Asset Management (Todd/Nelson Broms)

Camden Partners

China Grand
Cynergy Brookline Healthcare Fund

Dabar Investment Associates

Dandrew Partners (FO)

Easton Capital

Ellington Healthcare Partners / NSIP

Elser & Co.
Emerging Star Capital

Excelyrate (Mass Inn Labs VC Fund)

Fortress Biotech

4Bio Capital 

Gonzalez Family Office

Good Health Capital

Gore Range Capital

Gorlin Companies SFO

GSK Ventures

Harvard FO Club

Healthbox (Intermountain Health VC)

HIG Bio

International Cancer Impact Fund

Isaac Blech

JD Capital 

Keiretsu Forum

Kingdon Holdings

Landmark Angels

Leaf Capital

Leukemia and Lymphoma Society VC Fund

Lincoln Park Capital 

Lionchase 

Lopes de Souza (SFO)

LS Works

Maxim Merchant Banking & Private Equity

M Ventures (Merck Ventures)

MedPro Investors

Mid-Atlantic Angels

Momentum Biotech

Monarch Holdings 

Murdock Capital / Murdock Opportunity Fund

NJ Angels

Olympus Corporation Venture Capital

OPKO

OneMed Market

Park Avenue Capital

Patriot Strategies 

Puck Ventures (FO)

Remiges Ventures

Sandbox (BC/BS VC Fund)

Sixiang Holdings (SFO)

Syzygy Therapeutics Management

3VS1 

Touchdown VC

Varana Capital

Vista Capital
Wellington Management 
Willet (Bloomberg FO)

YuanMing Capital 

T = registered, but tentative

INVESTORS FROM PRIOR LIFE SCIENCE CONFERENCES

1315 Capital
315 Ventures, Ltd.

6th Dimension
Abbingworth
Aceras Partners

ARCH Ventures

Acrewood Holdings SFO

Aberdeen

Aegis Sciences Corp.
Agnovos
AIM-HI Cancer Fund
Alchemist Ventures
Alignment Ventures, LLC
Alloy Ventures
Alpha Bronze
Alzheimer's Drug Discovery Foundation
Amgen Consultant
Amkey Ventures LLC
AngelMD
Angels + LifeInfoSci Investors
Aphelion Capital
ARCHNOVA MFO
Arcus Ventures
Aristar Capital
Artiman Ventures

Aristor Capital NYC

Arix Biosciences Fund
ARCH Ventures

Ascension Ventures

Asia America
Asset Management Ventures
ATEM Capital
B Castle Smith & Co
Band of Angels

Bay City Capital
Bayer Pharma
BHNVN Israel

Beechwood FO

Bessley Capital

BioAdvance
BioPacific Investors
BioScience Managers
Blackwood Capital

Black Coral Capital

Blackstone River Advisory

Blue Lane Capital
Boler Biotech Consulting
Bracknor Investment Group
Brain Trust Accelerator Fund
Bridle Path Investments
Brilli Medical
Brookline
Brooks Medtech, LLC
Bund Capital
Burrill LLC
Button
Cambridge Blue Group
CapGenic Advisors
Capital Family Office
Capital IP
Capital Midwest Fund
Cardea Medsystems Co. Ltd.
Cardinal Health
Cathay Capital
CDF Ventures

Centricity Financial

Chen Financial

CIT GAP Funds
Claremont Creek Ventures

Clarus
CM Capital Corporation
CoSci Med-Tech
Crosswave Management
Crown Advisors Mgmt
CTIC Capital
D3 (Drug Discovery and Development)

Dabar Investment Associates

Dandrew Partners

DANEN VENTURES

DAS Capital

Dawson James Securities

Decheng Capital
Discover Fund Management
Diversified Portfolio Strategies
DKR
Dorset Capital LLC
DST Systems
Dynamik Capital
Easton Capital Investment Group

Edelson Technology Ventures

EGB Advisors PR LLC
Eight Roads Ventures / Fideltiy
Excel Venture Management
F-Prime (Fidelity)
Facilitated Growth
Felman Family Office
Fir Hill LLC
First Island Capital
FordPharma
FOS Capital LLC

Fortress Biotech

Fosun International

Fosun Pharmaceutical GroupFundRx
G5 Ventures
GARB Holdings
Genome BC
Genspring
GF Investment
Gimv
Glenmede MFO
Global-Biotech- Network
Global Corporate Finance
Gloria Group

Golden Seeds
Gopher Asset Management

Gonzalez Family Office

Gore Range Capital

Gorlin Companies SFO

GP Capital
GP Healthcare Capital
Great Point Partners
Greater Zurich Area
Greer Anderson MFO
Grey Sky Venture Partners
GSK
Guangzhou Wondfo Biotech Ltd
Harbert Growth Partners
Harvard Angels
Harvard FO Club
Healthcare Angels
Healthcare Investors, LLC
HealthQuest Capital
HealthX Ventures
Helicase Venture
HighBank Capital Partners
HighCape Partners
Hillhouse Capital
HUAQI Capital
Ignite Capital Partners, Inc.
IHSV Family Office
Image Analysis Group
Illumina Ventures

International Alliance Associates (MFO)

International Cancer Impact Fund

Intervalent
IPF Partners
iQX Investments
IWEUS CAPITAL

J. Sagar Associates
Jefferson Investors LLC

Jina Ventures Inc.
JP Morgan
Juggernaut Capital Partners
Kaitai Capital
Kalms & Partner Consulting
KIC Ventures
Knoll Capital Management
Kodiak Capital Group
KPI Therapeutics
Kumar CADD

L2 Capital
LAMAMED SOLUTIONS
Landmark Angels/Family Office
LCC Properties Group

Leaf Capital

LeMac Capital
Leukemia and Lymphoma TAP Fund

Lexden Capital

Life Science Angels
Lincoln Park Capital
Little Gem Life Sciences
LSCM
Lumira Capital
Lyfe Capital
Lymo Ventures
Lynx Financial

MABA

Maida Health
Malbone Capital
Mann Bioinvest Limited
Mark Kingdon Foundation
Maxim - Venture Capital
MBL Venture Capital Co., Ltd.
Med Qiao Group
Medical Growth Partners
MedPro Investors LLC
Medtech
MedTree LLC
Medtronic
MedVenture Partners, Inc
Mehta Partners + Viram

Merck
Merck Ventures
M-Ventures (Merck Germany)
Mid-Atlantic Bio Angels
Milestone Capital
Miracle Genomics Capital
MIT Alumni Angels
Mitsui Global Investment

MPM
Momentum Biotech
Monovo Phamaceuticals
Morely Venture Partners
Mount Lucas Management
Murdock CapitalNational Institutes of Health
New Age Ventures LLC
New Science Global Healthcare
NGN Capital
NJ Angels
NIH
North River Venture Capital
NOVARTIS
NSIP LLC
Object N Family Office
Objective Capital Partners, LLC
OceanIQ Capital
Olympus
OPKO
Opto Capital Group
OpusPoint Partners
OrbiMed
OurCrowd
PARK AVE CAPITAL
Peppermint Venture Partners
Persching Square Capital
PEX Capital

PHG

Principal Capital Imvestments
Qiming Venture Partners
R Wesley Capital
RBV Capital
River Cities Capital Funds
Roche
Roche Ventures
Rockwell Medical
R-Squared Capital
RTS
Ruddigore
Sagres Partners
SAIF Partners
SDIC Fund Management
SDL VENTURES
SECM
Second Angel Fund
SGH Capital
Shah Capital
Shuster Capital
Signatures Capital
Silicon Valley Bank
Sinocurrent Investment Corp.
Sixiang Holdings SFO
Skyview MFO
SPIRE Bioventures
Springhood Impact Ventures
Sprout Medical
SR One (GSK Venture Fund)
StartEngine
Stern Aegis
Stentson Family Office
Stern Aegis
Styandk Family Office
Synergy Partners International
T1D Fund
Tech Coast Angels
TEEC ANGEL FUND
Teijin Limited
Telegraph Hill Partners
The Channel Group
The iQ Group
The McNair Group
The Oxford Club
The RavenOye Group LLC
The Trendlines Group
Tianjin Academy of Medicine
Tianshi Capital
Touchdown Ventures
Trust Bridge partners
UpHonest Capital
US Angels Investors
Vector Capital Associates
VenBio
Venture
Venture DNA
VIGCO
Virtus Inspire Ventures
Vitangcol
VIVARI, Ltd
Volcano Capital
Wellington Partners
Wexford Capital LP
Whale Bay Capital

WuXi Ventures

Zacks Investment Research
ZeroTo510

© 2019 Oncology Investor Conference Series